SeaStar Medical Holding Corporation (ICU)
- Previous Close
3.2600 - Open
3.2700 - Bid 3.1700 x 300
- Ask 3.3000 x 300
- Day's Range
3.2300 - 3.3899 - 52 Week Range
3.2300 - 42.9250 - Volume
22,384 - Avg. Volume
75,243 - Market Cap (intraday)
13.539M - Beta (5Y Monthly) -1.11
- PE Ratio (TTM)
-- - EPS (TTM)
-18.5500 - Earnings Date Nov 12, 2024 - Nov 18, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
18.00
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
www.seastarmedical.comRecent News: ICU
View MorePerformance Overview: ICU
Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ICU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ICU
View MoreValuation Measures
Market Cap
13.75M
Enterprise Value
15.71M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-308.09%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-32.62M
Diluted EPS (ttm)
-18.5500
Balance Sheet and Cash Flow
Total Cash (mrq)
1.18M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-5.69M
Research Analysis: ICU
View MoreCompany Insights: ICU
ICU does not have Company Insights